CN101862334A - Application of evodiamine in preparation of preparation for resisting white spot syndromevirus - Google Patents

Application of evodiamine in preparation of preparation for resisting white spot syndromevirus Download PDF

Info

Publication number
CN101862334A
CN101862334A CN201010198342A CN201010198342A CN101862334A CN 101862334 A CN101862334 A CN 101862334A CN 201010198342 A CN201010198342 A CN 201010198342A CN 201010198342 A CN201010198342 A CN 201010198342A CN 101862334 A CN101862334 A CN 101862334A
Authority
CN
China
Prior art keywords
evodiamine
preparation
prawn
white spot
syndromevirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201010198342A
Other languages
Chinese (zh)
Other versions
CN101862334B (en
Inventor
章晓波
智斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN2010101983420A priority Critical patent/CN101862334B/en
Publication of CN101862334A publication Critical patent/CN101862334A/en
Application granted granted Critical
Publication of CN101862334B publication Critical patent/CN101862334B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides application of evodiamine in the preparation of a preparation for resisting white spot syndromevirus. Evodiamine can act on the protein essential for the apoptosis pathway of prawns, so the small molecules can be utilized to prepare the preparation for resisting the white spot syndromevirus so as to greatly enhance the resistance of the prawns to the white spot syndromevirus (WSSV) and reduce the fatality rate. The advantages of the invention are mainly embodied in that: the evodiamine can effectively induce activation of the PjCaspase, greatly enhance the resistance of the prawns to the white spot syndromevirus (WSSV) and reduce the fatality rate; and because the evodiamine is the medicament which is widely used in human body for improving the immunity, the evodiamine has no toxicity to the human body, and the prawns using the evodiamine can be enjoyed with safety no matter whether the medicament is completely metabolized.

Description

The application of rutaecarpin in the preparation of the anti-prawn white spot syndrome of preparation
(1) technical field
The present invention relates to the application of rutaecarpin (Evodiamine) in the preparation of the anti-prawn white spot syndrome of preparation.
(2) background technology
Prawn is the most dominant crustacean in tropical and subtropical zone shallow sea.Because its kind is many, population quantity is big, and reproductive capacity is strong, and growth is rapid, and the meat flavour deliciousness has very high economic worth.Reason owing to aspects such as environmental pollution, cultural technique, disease controls, prawn, particularly Penaeus monodon (Penaeus monodon), Penaeus vannamei (Penaeus vannamei), Chinese prawn (Penaeuschinensis) and japonicus (Marsupenaeus japonicus) etc., very easily be subjected to virus infraction, and cause a large amount of losses.(White spot syndrome virus WSSV), is the main cause of disease that causes most serious harm in the prawn culturing to white spot syndrome virus (WSSV).Make full use of innate immune system and the immunologic mechanism of prawn, resist virus by the disease-resistant mechanism that stimulates prawn targetedly, for prevention, the treatment of shrimp disease, the economic benefit that improves prawn culturing has great importance.
Prawn is one of most important sea-farming product, but since generation nineteen ninety, be subjected to the serious threat of disease always, especially white spot syndrome virus (WSSV) (white spot syndromevirus, WSSV) be the main cause of disease of harm prawn culturing, its pathogenecity is strong, and spread scope is wide, cause tremendous loss for world's shrimp culture industry, yet still do not have the effectively preventing method so far.
Many researchs at shrimp disease only rest on application owing to it, not the disease-resistant mechanism of resultant medicine are carried out more deep discussion, so the application of its medicine has been subjected to certain restriction.Owing to can't analyze at its mechanism of action, the problem that produces in these drug use processes also can not get answer, and then can't effectively solve simultaneously.Therefore, it is very necessary to study the disease-resistant medicine of known pharmacology.
Prawn is mainly resisted disease by processes such as its physical barriers, stress, congenital humoral immunization, cell physiological adjustings as a member of invertebrates.Apoptosis is as removing old and feeble and paracytic main mechanism, prawn catch an illness cell removing and prevent that virus has important function in spreading, be the important means of prawn disease resistance.And be the important weapon that to resist viral infringement.
Two subfamilies in the Caspase protein family are served as the initial sum effect protein respectively in apoptosis, be apoptotic key protein.Serve as the caspase-8,9 etc. of initiation, receive apoptotic signal after, can cause the caspase cascade reaction then by activating from montage; Serve as the caspase-3,6 of effect effect, structural protein and the functional protein in the born of the same parents that can directly degrade such as 7, cause apoptosis.
(3) summary of the invention
The object of the invention provides the application of rutaecarpin (Evodiamine) in the preparation of the anti-prawn white spot syndrome of preparation.
The technical solution used in the present invention is:
The application of rutaecarpin (Evodiamine) in the preparation of the anti-prawn white spot syndrome of preparation.
Rutaecarpin, extraction is from the fruit of rutaceae Fructus Evodiae [Evodia rutaecarpa (Juss.) Benth.] and congener stone tiger [E.rutaecarpa (Juss.) Benth.var.officinalis (Dode) Huang], CAS:518-17-2, structural formula is as follows:
Figure GDA0000022241010000021
Rutaecarpin has and is good for the stomach, eases pain, ends and retch and end effect such as acid eructation; Diuresis is arranged; Escherichia coli there is powerful inhibitory action; Ascaris suum there is remarkable insecticidal action; Shrink uterus and boosting in addition; Treatment degenerative brain disorder and apoplexy have certain curative effect.The present application people finds that this micromolecule can act on prawn apoptosis pathway key protein, therefore can utilize this micromolecule to prepare the preparation of anti-prawn white spot syndrome, can greatly strengthen the resistance of prawn to prawn white spot syndrome (WSSV), reduces fatality rate.
Described rutaecarpin can be used for preparing the preparation of inducing the PjCaspase protein activation.
Preferably, described preparation is an intramuscular dose, and wherein the injected dose of Evodiamine is 1~5 μ g/g shrimp (about preferred 3.5 μ g/g shrimps).
Evodiamine of the present invention promptly acts on the relevant micromolecule of the anti-white spot syndrome of prawn of prawn apoptosis pathway key protein PjCaspase.By direct injection Evodiamine or carry out feeding and can strengthen the opposing of prawn by activating the proteic activity of PjCaspase to virus, greatly strengthen the resistance of prawn to prawn white spot syndrome (WSSV), reduce fatality rate.
Beneficial effect of the present invention is mainly reflected in: Evodiamine of the present invention can effectively induce the proteic activation of PjCaspase, greatly strengthens the resistance of prawn to prawn white spot syndrome (WSSV), reduces fatality rate; Because Evodiamine is the medicine of widely used raising immunity in human body, and human body is not had toxicity, use the prawn of Evodiamine, no matter whether it can relieved eat drug metabolism fully.
(4) description of drawings
Fig. 1 be Evodiamine in cell with the checking of Caspase protein binding ability;
Fig. 2 is the influence of Evodiamine to apoptosis activity; A is that the activity of apoptosis index effect enzyme Caspase3 detects; B is an apoptosis index TUNEL activity;
Fig. 3 is the influence of Evodiamine to virus replication;
Fig. 4 is the influence of Evodiamine to the mortality rate of infection WSSV prawn; Abscissa is represented natural law, and vertical coordinate is represented mortality rate.
(5) specific embodiment
The present invention is described further below in conjunction with specific embodiment, but protection scope of the present invention is not limited in this:
Embodiment 1:
1, the checking of the binding ability of Evodiamine and PjCaspase:
1.1 amplification PjCaspase gene.
1.1.1 the prawn tissue cDNA is synthetic:
1.1.1.1 the extraction of prawn total tissue RNA:
1) gets the fresh and alive 200mg of organizing of prawn (japonicus is available from food market, Hangzhou, Zhejiang province city), in 800 μ L Trizol (BBI company), grind rapidly.
2) put 5min on ice.
3) (phenol and chloroform equal-volume mix the back and use 0.1mol/LTris.HCl (pH7.6) extracting several times with this mixture of balance to add 200 μ L phenol/chloroformic solutions, put in the Brown Glass Brown glass bottles and jars only, cover isopyknic 0.01mol/l Tris.HCl (pH7.6) liquid layer above, be stored in 4 ℃; Draw lower floor's solution with suction pipe during use), behind the vibration mixing 12, the centrifugal 10min of 000rpm.
4) pipette supernatant to the equivalent isopropyl alcohol.
5) vibration mixing after 12, the centrifugal 10min of 000rpm.
6) precipitation does not have RNA enzyme distilled water dissolving back adding 1 μ LDNase I (RNaseFree) (TaKaRa) with 50 μ L, digests 1 hour.
7) repeating step 3)~5).
8) precipitation is washed twice with 300 μ L80% (v/v) ethanol.
9) 12000rpm, after 2min dried ethanol, 50 μ L did not have the dissolving of RNA enzyme distilled water.
1.1.1.2 the reverse transcription of total RNA obtains cDNA:
Following compositions is put into the Eppendolf pipe of a RNase-free:
Total RNA 4g
Oligo(dT)(500μg/mL) 1μL
75 ℃ of degeneration 5min, ice bath, adding subsequently immediately:
5 * reverse transcriptase buffer, 4 μ L
4 kinds of dNTPs mixed liquors, the 2 μ L of each 10mmol/L
M-MLV?RT(RNase?H-)(200U/μL)(TaKaRa) 1μL
Water complements to 20 μ L
25 ℃ of reaction 10min, behind 42 ℃ of reaction 30min, 70 ℃ of heating 15min cessation reactions.
1.1.2PCR amplification:
Synthesize following primer (being depicted as the restriction enzyme site of the line part of introducing in the bracket) according to the gene reading frame sequence of having determined:
5’-AT CCCGGGATGGACGAGGTAATCCAG-3’(SmaI)
5’-TT CTCGAGTCACTGTGGGGCGGAG-3’(XhoI)
With prawn cDNA is template, the genetic fragment that pcr amplification is special.In the Eppendorf of 0.5mL pipe, add:
10 * PCR reactant liquor, 5 μ L
dNTP(2.5mmol/L?each) 4μL
Template (about 1 μ g/ μ L) 2 μ L
Each 1 μ L of 20mol/L gene-specific primer
Taq enzyme (TaKaRa) 1U
Add H 2O is to cumulative volume 50 μ L
Carry out pcr amplification by the following method: 95 ℃ of 5min; 94 ℃ of 30s, 58 ℃ of 30s, 72 ℃ of 1.5min, 35 circulations; 72 ℃ are extended 10min.
1.1.3 fragment reclaims:
Reclaim dna fragmentation according to a conventional method from agarose gel, the glue recovery test kit of producing with omega is an example:
1) cuts off the agar caked sugar that contains DNA, make it as far as possible little, put into the 1.5mL centrifuge tube.If it is agarose weight less than 100mg, is mended to 100mg with distilled water, unlikely too little to guarantee the system cumulative volume;
2) ratio that adds 300 μ L S1 liquid in every 100mg agarose adds S1 liquid (test kit carries), puts 50 ℃ of water-bath 10min, and the agar caked sugar is dissolved fully, and every 2min puts upside down mixing once;
3) agarose solution after will dissolving moves into adsorption column, and the centrifugal 30s of 7000rpm outwells the liquid in the collecting pipe, adsorption column is put into same collecting pipe again;
4) add 500 μ L W1 liquid (test kit carries) in adsorption column, the centrifugal 15s of 7000rpm outwells the liquid in the collecting pipe, and adsorption column is put into same collecting pipe;
5) add 500 μ L W1 liquid in adsorption column, leave standstill 1min, the centrifugal 15s of 7000rpm outwells the liquid in the collecting pipe, and adsorption column is put into same collecting pipe;
7) the centrifugal 1min of 7000rpm;
8) adsorption column is put into the centrifuge tube of a clean 1.5mL, central authorities add 10 μ L sterilized water at adsorbed film, leave standstill 1min, and the centrifugal 1min of 10000rpm is stored in-20 ℃ with the EP pipe.
Transform carrier 1.2 be cloned into PIZ:
1.2.1 endonuclease reaction:
In 0.5mL Eppendorf pipe, add successively:
Restriction endonuclease buffer (10 *) is 2 μ L (TaKaRa)
The about 0.5 μ g of DNA
Restriction endonuclease (TaKaRa) 0.5 μ L
Add water to cumulative volume 20 μ L
37 ℃ of water-bath 2~3h.70 ℃ of 15min inactivations.
Reclaim according to a conventional method
Be transformed into competent escherichia coli cell 1.2.2 connect
1) (original pIZ/V5-His carrier is connected into EGFP albumen and is transformed available from Invitrogen 6 μ L purpose fragment+1.5 μ L in advance with the transformation pIZ/V5-His carrier of enzyme double digestion.The EGFP fragment can obtain by buying pEGFP (BD Biosciences Clontech))+1 μ L T4buffer (TaKaRa)+0.25 μ L T4Ligase (TaKaRa)+1.5 μ LH 216 ℃ of connections of O are spent the night.
2) get the DH5 α competent cell of-70 ℃ of preservations, make it melt the back with hand rubbing and flick with finger, the mixing thalline adds an amount of plasmid or connects product, places 30min on ice.
3) 42 ℃ of water-bath thermal shock 90s, ice bath 1~2min rapidly.
4) add 400 μ L LB fluid mediums, low speed (100rpm) shakes 45min on 37 ℃ of shaking tables.
5) draw bacterium liquid 100~200 μ L, evenly coat on LB (the containing 100 μ g/mL Amp) flat board, dull and stereotyped room temperature leaves standstill 20~30min, treat that bacterium liquid immerses culture medium after, be inverted in 37 ℃ of overnight incubation.
(6) bacterium colony PCR primary dcreening operation recon, enzyme action are identified the back order-checking.
1.3 High Five cell is advanced in transfection
Sequence verification is inserted fragments sequence correct (its sequence is shown in SEQ ID NO:1) back:
A) mix 100 μ L ExpressFiveSFM culture medium (Invitrogen) that contain 1 μ g clone and 100 μ L ExpressFiveSFM culture medium (Invitrogen) culture medium that contain 1 μ g cellinfectin (Invitrgen).
B) leave standstill 45min.
C) add 800 μ L ExpressFiveSFM culture medium (Invitrogen), mixing.
D) join in the clear HighFive cell (Invitrogen) of collapse due to massive hemorrhage, room temperature leaves standstill 4h.
E) change clean ExpressFiveSFM culture medium (Invitrogen) overnight incubation.
1.4 after adding Evodiamine cultivates 48h together in ExpressFiveSFM culture medium (Invitrogen), with the proteic cell of single expression EGFP in contrast, the cell of expressing PjCaspase and EGFP fusion rotein is as experimental group, with Flex Station IImicroplate reader (Molecular Devices, USA) fluorescence intensity, the results are shown in Figure 1, abscissa is represented the consumption of Evodiamine, the longitudinal axis is represented the fluorescence intensity (being the binding ability of Evodiamine and PjCaspase) of cell, and as seen from the figure: Evodiamine can combine with Caspase albumen in cell effectively.
2, Evodiamine is to the influence of apoptosis activity:
2.1 sample process:
Get 20 one group of big or small well-balanced prawn, respectively injecting normal saline (100 μ L), WSSV virus (10 4Copy), WSSV virus (10 4Copy)+Evodiamine (dosage is that 3.5 μ g/g body weight shrimps are each, with the equivalent physiological saline solution), Evodiamine (dosage is that 3.5 μ g/g body weight shrimps are each, with the equivalent physiological saline solution).Wherein micromolecule Evodiamine injects preceding 12 hours, the injection in 0,12,24 hour of injection back at WSSV, and other group after-teemings are simultaneously penetrated equal normal saline and handled in contrast.Prawn after the processing was at 24,36,48 hours blood samplings.
2.2Caspase active the detection:
(1) extracts prawn blood at 1: 1 with the 500U heparin sodium.
(2) with caspase3/7 reaction substrate powder with the reaction Buffer (
Figure GDA0000022241010000101
3/7assay kit Promega) mixes.
(3) with 100ul shrimp blood and 100ul reaction mixture mixing (
Figure GDA0000022241010000102
3/7 assaykit, Promega).
(4) 25 ℃ of following lucifuge incubations 3 hours.
(5) detect chemiluminescence with the chemiluminescence microplate reader
2.3Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) method detects apoptosis activity
(1) on microscope slide, evenly is coated with the shrimp hemocyte.
(2) microscope slide is immersed in 4% paraformaldehyde (worker is given birth in the Shanghai) solution, fix 25 minutes for 4 ℃.
(3) give a baby a bath on the third day after its birth time each 5 minutes under the room temperature with PBS.
(4) 2%Triton X-100 oozed 5 minutes in advance.
(5) PBS washes twice.
(6) with 100 μ L level pad (TUNEL test kit, Promega) balances.
(7) (the TUNEL test kit, Promega), 37 ℃ of lucifuge incubations are 1 hour in the wet box (be paved with the gauze that gets wet in the plastic lunch box and get final product, also can adopt the sharp clever product in Shanghai) to add 50 μ L rTdT.
(8) add 2 * SSC (TUNEL test kit, Promega) cessation reaction.
(9) PBS gives a baby a bath on the third day after its birth inferior.
(10) with 1 μ g/ml PI (Shanghai give birth to worker) solution-dyed 15 minutes.
(11) PBS gives a baby a bath on the third day after its birth inferior.
(12) microscopy under the fluorescence microscope.
Fig. 2 adopts the prawn of normal saline, WSSV virus, WSSV virus+Evodiamine, Evodiamine processing at 24,36,48 hours detected apoptosis activities.As seen from the figure, Evodiamine has greatly improved apoptosis activity.
3, Evodiamine is to the influence of virus replication:
3.1 the prawn genome extracts
Extract according to the total DNA of prawn after the processing of 2.1 methods with SQ Tissue Kit (Promega).
3.2Real-time PCR measures viral copy number
Synthesize the Taqman probe and compare 50 ℃ of 4min, (95 ℃ of 45s, 52 ℃ of 45s, 72 ℃ of 45s) 45 circulations of * with b-actin.Standard curve is made by the WSSV plasmid of concentration known.
Fig. 3 is for adopting WSSV virus, WSSV virus+Evodiamine (3.5 μ g/g, with physiological saline solution), detected WSSV virus copy number changed WSSV virus+Evodiamine (0.35 μ g/g is with physiological saline solution) prawn of handling at 36,48 hours.As seen from the figure, Evodiamine has effectively suppressed WSSV and has duplicated in that prawn is intravital.
3, mortality rate is measured and is got 20 one group of big or small well-balanced prawn, respectively injecting normal saline (100 μ L), WSSV virus (10 4Copy), WSSV virus (10 4Copy)+Evodiamine (dosage is that 3.5 μ g/g body weight shrimps are each, with the equivalent physiological saline solution), Evodiamine (dosage is that 3.5 μ g/g body weight shrimps are each, with the equivalent physiological saline solution).Wherein micromolecule is injected preceding 12 hours, the injection in 0,12,24 hour of injection back at WSSV, and other group after-teemings are simultaneously penetrated equal normal saline and handled in contrast.The record mortality rate.
The mortality rate variation of prawn in six days that Fig. 4 handles for adopting normal saline, WSSV virus, Evodiamine, WSSV virus+Evodiamine.As seen from the figure, Evodiamine effectively reduces the mortality rate of infection WSSV prawn and prawn is not had toxicity, can be extensive use of in prawn culturing.

Claims (3)

1. the application of rutaecarpin (Evodiamine) in the preparation of the anti-prawn white spot syndrome of preparation.
2. application as claimed in claim 1 is characterized in that described rutaecarpin is used to prepare the preparation of inducing the PjCaspase protein activation.
3. application as claimed in claim 1 or 2 is characterized in that described preparation is an intramuscular dose, and wherein the injected dose of Evodiamine is 1~5 μ g/g shrimp.
CN2010101983420A 2010-06-11 2010-06-11 Application of evodiamine in preparation of preparation for resisting white spot syndromevirus Expired - Fee Related CN101862334B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101983420A CN101862334B (en) 2010-06-11 2010-06-11 Application of evodiamine in preparation of preparation for resisting white spot syndromevirus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101983420A CN101862334B (en) 2010-06-11 2010-06-11 Application of evodiamine in preparation of preparation for resisting white spot syndromevirus

Publications (2)

Publication Number Publication Date
CN101862334A true CN101862334A (en) 2010-10-20
CN101862334B CN101862334B (en) 2012-07-04

Family

ID=42954394

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101983420A Expired - Fee Related CN101862334B (en) 2010-06-11 2010-06-11 Application of evodiamine in preparation of preparation for resisting white spot syndromevirus

Country Status (1)

Country Link
CN (1) CN101862334B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103734511A (en) * 2013-12-17 2014-04-23 浙江大学 Application of tryptophol serving as white spot syndrome-resistant feed additive

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426783A (en) * 2001-12-18 2003-07-02 吉林天药科技股份有限公司 Application of evodiamine in the preparation of medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426783A (en) * 2001-12-18 2003-07-02 吉林天药科技股份有限公司 Application of evodiamine in the preparation of medicine

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
《Acta Pharmacologica Sinica》 20040131 Zhang Y 等 Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis 83页摘要部分 1-3 第25卷, 第1期 2 *
《Developmental and Comparative Immunology》 20071126 Lei Wang 等 Requirement for shrimp caspase in apoptosis against virus infection 706页摘要部分 1-3 第32卷, 2 *
《Molecular Cancer Therapeutics》 20060919 Tae-Jin Lee 等 Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells 2398页摘要 1-3 , 第5期 2 *
《中国中医药信息杂志》 20050630 崔岚 等 吴茱萸碱药理作用研究进展 108-110 1-3 第12卷, 第6期 2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103734511A (en) * 2013-12-17 2014-04-23 浙江大学 Application of tryptophol serving as white spot syndrome-resistant feed additive
CN103734511B (en) * 2013-12-17 2015-04-29 浙江大学 Application of tryptophol serving as white spot syndrome-resistant feed additive

Also Published As

Publication number Publication date
CN101862334B (en) 2012-07-04

Similar Documents

Publication Publication Date Title
Wang et al. The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release
Li et al. Forsythoside a inhibits the avian infectious bronchitis virus in cell culture
CN106265764B (en) The application of IAP inhibitor and oncolytic virus in antineoplastic is prepared
Cai et al. Selective replication of oncolytic virus M1 results in a bystander killing effect that is potentiated by Smac mimetics
CN102716164B (en) Echinacea extract and preparation method of echinacea extract
Jin et al. Immunomodulatory activity and protective effects of polysaccharide from Eupatorium adenophorum leaf extract on highly pathogenic H5N1 influenza infection
CN101862334B (en) Application of evodiamine in preparation of preparation for resisting white spot syndromevirus
Bi et al. The bioactivities and potential clinical values of Angelica sinensis polysaccharides
CN102167726A (en) Method for separating and extracting active polypeptide and immune ribonucleic acid by utilizing blood and spleen of animal
CN101935346B (en) Mutated human-source fibroblast growth factor and application in treating endocrine diseases
KR20200091105A (en) Smart Palm Saewook Style System
CN101862444B (en) Application of interleukin 2 in preparing preparation for resisting prawn white spot syndrome virus
CN103642797A (en) Extraction method of total RNA of intermuscular bone of megalobrama amblycephala
CN103816531B (en) Fusion rotein prepares the purposes in medicine, health food or the food treating and/or preventing radiation damage
López‐Vázquez et al. Experimental infection of turbot, Psetta maxima (L.), with strains of viral haemorrhagic septicaemia virus isolated from wild and farmed marine fish
CN104546822A (en) Medical application of anhydroicaritin
CN102827749A (en) Ornithogalum saponins and paclitaxel health care liquor
CN102397549A (en) Pharmaceutical composition for treating cancers
CN101899466A (en) Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
CN101919873B (en) Nucleic acid medicament for resisting white spot syndrome viruses (WSSVs) and/or taura syndrome viruses (TSVs)
CN101649323B (en) Method for designing human aldehyde dehydrogenase 2 sequence according to preferred codon of pichia pastoris
CN104491496B (en) Application of the Gastrodin/Rhizoma Gastrodiae powder in anti-hepatic fibrosis medicines are prepared
Ohe Ivermectin treatment for COVID-19
EP3011964A1 (en) Compounds and associations for treating pancreatic cancer
Vilaça COVID‐19, malaria and animal spirits: a few intercultural metaphors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20150611

EXPY Termination of patent right or utility model